Filing of the 2013 Registration document
Avignon, May 5th 2014 - Naturex, world leader in speciality plant-based ingredients, has published its registration document for the year ended December 31st, 2013.
2013 Registration document
The 2013 Registration document was filed with the French Financial Markets Authority (Autorité des Marchés Financiers) on April 30th, 2014 under the number D.14-0456.
This document includes :
- the annual financial report for the year ended December 31st, 2013 according to article L 451-1-2 of Code monétaire et financier ;
- the Chairman of the Board of Directors' Report on Corporate Governance, internal control and risk management ;
- the report relating to the social, environmental and societal informations ;
- the information related to the Statutory Auditors'fees.
Copies of this document in French language are available free of charge, pursuant to applicable law, and can be downloaded from the company's web site www.naturex.fr, under the « Investors » section, as well as on www.amf-france.org.
English translation of this document will be soon available.
You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com
Financial schedule
| - Q1 2014 results: - 2014 H1 sales - 2014 first-half results - 2014 third-quarter sales - 2014 third-quarter results - Annual revenue - Annual results |
26 May 2014 25 July 2014 29 August 2014 4 November 2014 28 November 2014 3 February 2015 31 March 2015 |
4 Upcoming events
| - AGM | 26 June 2014 |
Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B
 |
Total number of shares comprising the share capital: 7,852,055 ISIN FR0000054694 NATUREX is a component of the CAC PEA-PME, CAC Small, Gaïa Index. Naturex is eligible for the "long only" Deferred Settlement Service (SRD). Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY. SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY |
About Naturex
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs more than 1,450 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
| Contacts | |
| Thierry Lambert Chairman and Chief Executive Officer Tel.: +33 (0)4 90 23 96 89 [email protected] |
Thierry-Bertrand Lambert Chief Financial Officer Tel.: +33 (0)4 90 23 96 89 [email protected] |
|
Carole Alexandre Investor Relations Tel.: +33 (0)4 90 23 78 28 [email protected] |
Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 [email protected] |
Communiqués de mise à disposition de documents :
- Modalités de mise à disposition de document de référence ou de ses actualisations
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-35825-2013-05-05-Registration-document-filing-2013.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Quelle: Actusnews
